Skip to content

Addiction: all studies

Page 446 of 855: studies 4,451 to 4,460 of 8,547, newest first. Back to the addiction overview

Research

Surface-based brain morphometry in schizophrenia vs. cannabis-induced psychosis: A controlled comparison.

Journal of Psychiatric Research September 1, 2022 Abhishek Ghosh, Simranjit Kaur, Raghav Shah et al.

BACKGROUND & AIM We examined group differences in cortical thickness and surface-parameters among age and handedness--matched persons with cannabis-induced psychosis (CIP), schizophrenia with heavy cannabis use (SZC), and healthy controls (HC). METHODS We recruited 31 men with SZC, 28 with CIP, and 30 with HC. We used the Psychiatric Research Interview for Substance and Mental Disorders to...

Relative reinforcing effects of dibutylone, ethylone, and N-ethylpentylone: self-administration and behavioral economics analysis in rats.

Psychopharmacology September 2022 Miaojun Lai, Dan Fu, Zeming Xu et al.

Following the emergence of methylone as one of the most popular synthetic cathinones, this group of novel psychoactive substance with names ending in "-lone," such as dibutylone, ethylone, and N-ethylpentylone, appeared on the recreational drug market. The pharmacological mechanisms of dibutylone, ethylone, and N-ethylpentylone are well understood; however, to date, the reinforcing effects of...

DOI: 10.1007/s00213-022-06173-x (opens in new tab) Full text (opens in new tab) Dibutylone Ethylone Methamphetamine N-ethylpentylone +3

Extended mind and artifactual autobiographical memory

Mind & Language September 1, 2022 Richard Heersmink

In this paper, I describe how artifacts and autobiographical memory are integrated into new systemic wholes, allowing us to remember our personal past in a more reliable and detailed manner. After discussing some empirical work on lifelogging technology, I elaborate on the dimension of autobiographical dependency, which is the degree to which we depend on an object to be able to remember a...

Effect of 4-Week Heartfulness Meditation on Stress Scores, Sleep Quality, and Oxidative and Inflammatory Biochemical Parameters in COVID-19 Patients after Completion of Standard Treatment – A Randomized Controlled Trial

International Journal of Yoga September 1, 2022 Senthil K Subramanian, Vidya D Sripad, Amudharaj Dharmalingam et al.

Context: COVID-19-affected patients showed increased stress, impaired sleep quality, altered complete blood count, and increased inflammatory and oxidative parameters. Yoga is an add-on nonpharmacological treatment that is established to normalize the abovementioned parameters. Heartfulness meditation is a form of Raja yoga. Aims: The present study aimed to study the effects of 4 weeks of...

PHYSICAL AND MENTAL PURIFICATION THROUGH VIPASSANA

SCHOLARLY RESEARCH JOURNAL FOR INTERDISCIPLINARY STUDIES September 1, 2022 Jayesh R. Jadhav

Modern life moves so quickly that there isn't even time to breathe. Science, business, political structures, and other areas of human endeavour have advanced dramatically. They are seeing an upsurge in mental illness, delinquency, crime, drug addiction, alcoholism, and suicide, among other things, despite their advancements in these domains. Social issues have always existed, ranging from...

Interest of drug checking supply: Results of 3 years of activity in Geneva

Annales de Toxicologie Analytique September 1, 2022 M. Augsburger, J. Déglon, Christèle Widmer et al.

Aim: Swiss drug policy aims to reduce recreational drug consumption and its negative consequences. The strategy is based on a four pillars concept: prevention, therapy, harm reduction and repression. Among harm reduction programs drug checking (DC) facilities have emerged, allowing drug users to check the presence of adulterants or other non-expected substances, and to gain information...

Psychedelics for Psychiatric Disorders: Promise, Not Panacea

Psychiatric Annals September 1, 2022 Mitch Earleywine, Zachary Herrmann 5 citations

Initial promise and dire need have inspired the multiple research programs of the second psychedelic renaissance. Serotonergic psychedelics (psilocybin, lysergic acid diethylamide, and ayahuasca) have decreased end-of-life anxiety in cancer patients, treatment-resistant depression, alcohol dependence, social anxiety in autistic adults, and nicotine dependence when applied with supportive...

The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.

Cureus September 1, 2022 Joshua S Kurtz, Neal A Patel, Julian L Gendreau et al. 35 citations

Although early therapeutic research on psychedelics dates back to the 1940s, this field of investigation was met with many cultural and legal challenges in the 1970s. Over the past two decades, clinical trials using psychedelics have resumed. Therefore, the goal of this study was to (1) better characterize the recent uptrend in psychedelics in clinical trials and (2) identify areas where...

The use of psychoactive substances in the treatment of mental disorders

Alcoholism and Drug Addiction August 31, 2022 Katarzyna Karaś, Katarzyna Groblińska, Krzysztof Szczygieł et al.

Research on the use of psychoactive substances in mental disorder treatment has become increasingly important over the last 50 years. Numerous publications suggest their effectiveness in the treatment of many diseases, including depression and anxiety disorders, PTSD, psychoactive substance dependence, ADHD and Tourette’s Syndrome. Particularly noteworthy is the use of psychedelics such as...

DOI: 10.5114/ain.2021.111791 (opens in new tab) Full text (opens in new tab) Mental disorders Treatment Psychoactive substances.

Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor

Nature Neuroscience August 30, 2022 Polymnia Georgiou, Panos Zanos, Ta-Chung M. Mou et al.

We show that the sex of human experimenters affects mouse behaviors and responses following administration of the rapid-acting antidepressant ketamine and its bioactive metabolite (2R,6R)-hydroxynorketamine. Mice showed aversion to the scent of male experimenters, preference for the scent of female experimenters and increased stress susceptibility when handled by male experimenters. This...